In agreement, studies indicate that RBP4 can be considered a biomarker of glomerular diseases, such as diabetic nephropathy [41,42], and proximal tubulopathies, such as Falconi syndrome [42]. The gene discussed is RBP4; the disease is glomerular disorder.